Covagen AG
Records under this name other than patents Covagen AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Covagen AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,315,557 | Novel IL-17A Binding Molecules and Medical Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,323,095 | Antibody-fynomer conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,351,267 | FGFR3 Binding Molecules Lapsed on the fee record Ended Jun 7, 2026 · High confidence | Lapsed on the fee record | Ended Jun 7, 2026 | High confidence |
| US 9,790,475 | Human Serum Albumin Binding Compounds and Fusion Proteins Thereof Lapsed on the fee record Ended Oct 17, 2025 · High confidence | Lapsed on the fee record | Ended Oct 17, 2025 | High confidence |
| US 9,593,314 | Binding molecules with antitumoral activity Lapsed on the fee record Ended Mar 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 14, 2025 | From the USPTO record |
| US 10,722,589 | FGFR3 Binding Molecules Formerly held Lapsed on the fee record Ended Jul 28, 2024 · High confidence | Lapsed on the fee record | Ended Jul 28, 2024 | High confidence |
| US 9,376,477 | IL-17 Binding Compounds and Medical Uses Thereof Formerly held Lapsed on the fee record Ended Jun 28, 2024 · High confidence | Lapsed on the fee record | Ended Jun 28, 2024 | High confidence |
| US 10,364,419 | Human Serum Albumin Binding Compounds and Fusion Proteins Thereof Lapsed on the fee record Ended Jul 30, 2023 · High confidence | Lapsed on the fee record | Ended Jul 30, 2023 | High confidence |
| US 9,085,760 | Chymase binding compounds and medical uses thereof Lapsed on the fee record Ended Jul 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 21, 2023 | From the USPTO record |